Details for: CL0002355

Cell ID: CL0002355

Cell Name: primitive red blood cell

Description: A large nucleated basophilic erythrocyte found in mammalian embryos. This cell type arises from the blood islands of yolk sacs and expresses different types of hemoglobins (beta-H1, gamma-1 and zeta) than adult erythrocytes. Considered a type of erythroblast as this cell type can enucleate in circulation.

Synonyms: primitive erythroblast, primitive erythrocyte, primitive erythroid cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for primitive red blood cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for primitive red blood cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for primitive red blood cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for primitive red blood cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  primitive red blood cell (CL0002355)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [primitive red blood cell](/details-cell/CL0002355), also known as a primitive erythroblast, is a large, nucleated erythroid cell found in the yolk sacs of mammalian embryos. Its primary function is to produce and circulate embryonic hemoglobins, providing the first source of oxygen to developing tissues. The gene significance profile of this cell is dominated by markers indicating exceptionally high metabolic activity and robust machinery for iron management and protein synthesis. The high specificity scores ([csi_z]) for genes like [YBX1](/details-gene/4904) (transcription/translation regulation), [FTH1](/details-gene/2495) (iron storage), and numerous mitochondrial components suggest that this cell is a highly specialized biological factory optimized for the massive production of hemoglobin. ## Key Characteristics and Function Analysis of the top marker genes reveals several interconnected functional themes that define the [primitive red blood cell](/details-cell/CL0002355). * **Intensive Iron Metabolism:** The presence of both ferritin heavy chain ([FTH1](/details-gene/2495)) and ferritin light chain ([FTL](/details-gene/2512)) as top markers underscores the cell's central role in sequestering and managing iron. This is a critical prerequisite for heme synthesis, the core component of hemoglobin. The high specificity of these genes suggests that iron handling is a defining feature of this cell's identity. * **High Energy Production:** A significant number of top markers are components of the mitochondrial electron transport chain and ATP synthase complex, including [ATP5F1E](/details-gene/514), [NDUFA4](/details-gene/4697), [COX7C](/details-gene/1350), [UQCRB](/details-gene/7381), and [ATP5F1B](/details-gene/506). The glycolytic enzyme [GAPDH](/details-gene/2597) is also a highly specific marker. This collective signature points to a massive energy demand, likely fueling the ATP-intensive processes of globin chain synthesis, protein folding, and cellular maintenance during its rapid differentiation. * **Robust Transcriptional and Translational Activity:** The top marker, [YBX1](/details-gene/4904), along with others like [PCBP2](/details-gene/5094), [ELOB](/details-gene/6923), and [BTF3](/details-gene/689), are all involved in regulating transcription and RNA processing. This indicates a highly active state of gene expression necessary to produce the vast quantities of globin mRNA and other essential proteins. Genes involved in protein quality control ([UBB](/details-gene/7314)) and modification ([OST4](/details-gene/100128731)) further support the notion of this cell as a protein production powerhouse. * **Terminal Differentiation State:** **Overall**, the anti-marker profile provides critical insight into what this cell is not. The low significance of genes involved in cell cycle progression and mitosis, such as the minichromosome maintenance proteins ([MCM2](/details-gene/4171), [MCM4](/details-gene/4173)) and kinetochore components ([KNSTRN](/details-gene/90417), [CENPA](/details-gene/1058)), strongly suggests that these cells have exited the cell cycle. This is consistent with their identity as erythroblasts undergoing terminal differentiation, where the focus shifts entirely from proliferation to the functional specialization of hemoglobinization, a process that culminates in enucleation. ## Clinical Significance and Contextual Roles The [primitive red blood cell](/details-cell/CL0002355) is fundamental to embryonic survival, as failures in this first wave of erythropoiesis can lead to severe anemia and fetal demise. The gene profile highlights processes that are central to both normal development and hematological disorders. The pronounced signature of iron metabolism genes ([FTH1](/details-gene/2495), [FTL](/details-gene/2512)) connects this cell type to the broader study of iron-deficiency anemias and iron-overload disorders. While these conditions are typically studied in the context of adult definitive erythropoiesis, understanding the foundational mechanisms in primitive erythropoiesis provides a developmental perspective on how iron homeostasis is established. Furthermore, many of the top markers, such as [YBX1](/details-gene/4904) and [BTF3](/details-gene/689), are noted for their roles in "in utero embryonic development." This reinforces the cell's critical, non-redundant function during early gestation. Disruptions in the expression of these highly active "housekeeping" genes within this specific cellular context could have profound and pleiotropic effects on embryonic development beyond just oxygen transport. The data suggest that the unique physiology of the primitive erythroblast relies on the exceptionally high-level expression of a suite of genes that, while broadly expressed, are fine-tuned to support its specialized function. ## Potential Mechanisms and Research Directions 1. **Hypothesis: Energy production in primitive erythroblasts is directly coupled to iron trafficking to support massive heme synthesis.** The co-enrichment of top markers for both mitochondrial respiration and ferritin-based iron storage suggests a tightly regulated system. We propose that the high mitochondrial activity is not just for general cellular energy but is specifically channeled to power the import, processing, and incorporation of iron into protoporphyrin IX, and that ferritin expression acts as a crucial buffer to prevent iron-induced oxidative stress in this high-flux environment. * **Surprising Findings:** It is noteworthy that general transcriptional regulators like [YBX1](/details-gene/4904) exhibit such a high cell-type specificity score ([csi_z]). This implies that the sheer magnitude of transcriptional and translational throughput in [primitive red blood cells](/details-cell/CL0002355) is a key feature that distinguishes them from nearly all other cell types, elevating the importance of these otherwise ubiquitous factors to that of defining markers. * **Testable Questions:** Does pharmacological inhibition of the mitochondrial electron transport chain in ex vivo cultures of yolk sac progenitors lead to a compensatory upregulation of [FTH1](/details-gene/2495) and [FTL](/details-gene/2512) to sequester unprocessed iron, and does it stall hemoglobinization? 2. **Hypothesis: The exit from the cell cycle is a required molecular switch that enables the terminal differentiation program in primitive erythroblasts.** The strong negative signature for genes involved in DNA replication and mitosis ([MCM2](/details-gene/4171), [MCM4](/details-gene/4173), [NCAPG](/details-gene/64151)) juxtaposed with the positive signature for metabolic and protein synthesis machinery suggests a fundamental trade-off. We hypothesize that key hematopoietic transcription factors actively repress the cell cycle machinery, thereby liberating the cell's resources and transcriptional machinery to execute the high-demand program of hemoglobin production. * **Surprising Findings:** The absence of specific embryonic globin genes (e.g., *HBZ*, *HBE1*) from the top markers list is unexpected given the cell's primary function. This may reflect the nature of the `csi_z` metric, which prioritizes genes with the most extreme expression levels relative to other cells. The top markers identified are likely expressed at levels even more exceptionally high than the globin genes, highlighting that the "support machinery" for hemoglobinization is as much a defining feature as the final product itself. * **Testable Questions:** If a key cell cycle regulator like [CDKN2C](/details-gene/1031) (a p18 inhibitor, which is an anti-marker) were knocked down in primary hematopoietic stem and progenitor cells differentiating towards the erythroid lineage, would this forced cell cycle entry lead to a measurable delay or reduction in the expression of top functional markers like [FTH1](/details-gene/2495) and [ATP5F1E](/details-gene/514)?